BB-10901

DRUG3 trials

Sponsors

ImmunoGen, Inc.

Conditions

Merkel Cell CarcinomaMultiple MyelomaOvarian CancerSCLCSmall Cell Lung Cancer

Phase 1

Safety Study Using Weekly Infusions of BB-10901 in Patients With Small Cell Lung Cancer

CompletedNCT00065429

ImmunoGen, Inc.Small Cell Lung Cancer

Start: 2003-04-30End: 2008-12-31Updated: 2012-07-18

BB-10901 in Treating Patients With Relapsed and/or Refractory Multiple Myeloma

CompletedNCT00346255

ImmunoGen, Inc.Multiple Myeloma

Start: 2005-04-30End: 2011-03-31Updated: 2013-04-23

BB-10901 in Treating Patients With Relapsed or Refractory Solid Tumors

CompletedNCT00346385

ImmunoGen, Inc.Merkel Cell Carcinoma, Ovarian Cancer, SCLC

Start: 2002-03-31End: 2011-10-31Updated: 2015-03-26